Live feed
·
INSIDERFilingvia Quantisnow
Chemomab Therapeutics Ltd. logo

Chemomab Therapeutics (CMMB) executive Mor sold 13,800 American Depositary Shares for $69.4K at $5.03 under a 10b5-1 plan

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

George Adi Mor (executive at Chemomab Therapeutics Ltd., CMMB) reported that they sold 13,800 American Depositary Shares for $69.4K at $5.03 between Oct 28, 2016 and Jan 3, 2023. After these transactions the filing shows 317,075 American Depositary Shares held directly and 251,147 American Depositary Shares held indirectly (By Kobi George, the Reporting Person's spouse).

Reporting person
Mor George Adi
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jan 3, 2023Open-market sale (S)American Depositary Shares1, 2-7,700$5.03$38.7K317,075 direct
Jan 3, 2023Open-market sale (S)American Depositary Shares1, 2-6,100$5.03$30.7K251,147 indirect

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Mar 15, 2018Grant or award (A)Option to Purchase American Depositary SharesOn 131,698 American Depositary Shares1, 3, 4+131,698--131,698 direct
Oct 28, 2016Grant or award (A)Option to Purchase American Depositary SharesOn 33,725 American Depositary Shares1, 3, 5+33,725--33,725 indirect

Holdings before and after

  • American Depositary Shares: 324,775 to 317,075 direct
  • American Depositary Shares: 257,247 to 251,147 indirect, By Kobi George, the Reporting Person's spouse
  • Option to Purchase American Depositary Shares: 0 to 131,698 direct
  • Option to Purchase American Depositary Shares: 0 to 33,725 indirect, By Kobi George, the Reporting Person's spouse

Footnotes from the filing

  1. 1. Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
  2. 2. This transaction was effected pursuant to a 10b5-1 plan entered into on September 19, 2022.
  3. 3. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
  4. 4. These options have vested and are exercisable as of the date hereof.
  5. 5. These options have vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.

Transaction codes in this filing

Open-market sale:
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.

FAQ

What did Mor report in this CMMB Form 4?

George Adi Mor (executive at Chemomab Therapeutics Ltd., CMMB) reported that they sold 13,800 American Depositary Shares for $69.4K at $5.03 between Oct 28, 2016 and Jan 3, 2023. After these transactions the filing shows 317,075 American Depositary Shares held directly and 251,147 American Depositary Shares held indirectly (By Kobi George, the Reporting Person's spouse).

How many CMMB shares does Mor hold after this filing?

The filing shows 317,075 American Depositary Shares held directly, 251,147 American Depositary Shares held indirectly (By Kobi George, the Reporting Person's spouse) after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

Was this CMMB insider sale made under a 10b5-1 plan?

The filing's footnotes mention a Rule 10b5-1 trading plan. Such a plan sets the terms of future trades in advance.

What does transaction code S mean on an SEC Form 4?

Code S marks a sale in the open market or a private deal. The insider received cash for these securities.

Historical context for CMMB

Earlier insider filings at CMMB

Quantisnow market dataNASDAQ
Chemomab Therapeutics Ltd. logo
CMMB
Chemomab Therapeutics Ltd.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2019
Get push alerts for CMMB

Follow CMMB and get a push notification the moment its next story breaks.

Full CMMB profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CMMB (Chemomab Therapeutics Ltd.) and more on Quantisnow.